Matt Sykes

Could you just provide a little bit more color on what's driving that growth? And how sustainable do you think that growth is, particularly in genomics as we move through 2025?

Should we start to see a faster cycle of new product introductions due to the resegmentation, or is it gonna be similar to the pace that we've seen in the past

Could you just talk about academic as a whole, including NIH, what that is in terms of percentage of RMS?

are you expecting any sort of improvement to that dynamic in the second half of 2025, or should we be thinking more about 2026

opportunities for any potential margin expansion and kind of what you could do on the cost side

do you think that vendor consolidation trend, which has already been in place, will accelerate in this environment

Patrick, one for you just on services growth. You said 6% in the quarter. A little bit below kind of the run rate you were doing last year

Do you think that if this tariff situation lasts a little bit longer than expected, meaning beyond Q2, there could be some shifts in the competitive landscape in China

can we extrapolate sort of that improving demand among that customer segment in Europe into other developed market regions like the US

you do have a manufacturing footprint there. Could you maybe remind us what your exposure is in terms of revenue shipped out of Mexico

wondering if the US had any kind of tariff pull forward just given the acceleration of high-single-digits

Could you maybe kind of give us a refresh on the competitive landscape, how you're winning business?

what are you looking for in terms of leading indicators in terms of seeing that turn?

could you maybe talk about any changes in order behavior or patterns where there's been a pull forward of inventories just to get ahead of tariffs

is it easier to flex an instrument manufacturing facility versus, say, consumables and reagents

Just on services, it came in a little bit lighter than what we were expecting. Is this just a natural output of just having a very high instrument placement growth

does this make you want to take advantage of the environment to perhaps invest a little bit more in upstream, either organically or inorganically

can you talk through the strength you saw in the Academic and Government section this quarter? And then what your expectations are going into 2025

Can you talk through the benefits of your Empower software? And then, any particular application areas where you see higher attachment rates